Skip to main navigation menu Skip to main content Skip to site footer
FrancoAngeli Journals

Saggi, Studi e Ricerche

No. 46 (2016)

Accessi venosi difficili e consumatori di sostanze: indagine sulle sedi di prelievo e sulle difficoltà di esecuzione

Submitted
aprile 21, 2017
Published
2017-04-21

Abstract

Introduction: injection drug users (IDUs) are a patients considered like a hard venous access category. The Addictions Department (Ser.D) screen and monitoring infectious diseases related to addiction through blood samples.
Aim: identify the mostly used site for taking of blood samples and assess whether there is difficulty in the execution.
Method: descriptive-observational study; it uses a monitoring template already used and isolates IDUs from non-injection drug users. Data is processed using Microsoft Excel®. The research was carried out from 25/02/2015 to 30/09/2015 on 163 patients. In 62% of cases blood sampling was performed in median cubital vein, respectively, 54% and 83% in IDUs in NIDU. The mean of attempts in IDU patients is 2, in NIDU is 1. In 18% of cases were ultrasound driven. In 2% arterial puncture was required. In 2% of IDUs blood sampling was
failed.
Discussion: the cubital vein is the mainly used and the first choice. In some cases, the patient requires blood withdrawal in different veins because cubital veins is used for substances or considered obliterated; in these situations the relationship is crucial. Health professionals find problems on the technical side, especially in IDUs, in finding a suitable venous access and on the relational building, balancing user requirements with the need to take the sample without altering the professional/ patient relationship.

References

  1. Osservatorio europeo delle droghe e delle tossicodipendenze Relazione europea sulla droga (2015), Tendenze e sviluppi, Lussemburgo. Disponibile da: www.emcdda.europa.eu/attachements.cfm/att_213154_IT_TDAT13001ITN1.pdf [consultato il 01/10/2015].
  2. Karimi M., Ghaheri H., Assari S., Ahmadi K., Moghani Lankarani M., Moghani Lankarani R., Narenjiha H., Rafiey H., Tavakoli M., Jafari F. (2014), “Drug Injection to Sites other than Arm: A Study of Iranian Heroin Injectors”, Front Psychiatry, 7: 5-23.
  3. Alcantara A.L., Tucker R.B., McCarroll K.A. (2002), “Radiologic study of injection drug use complications”, Infect Dis Clin North Am, 16(3): 713-43.
  4. Darke S., Ross J., Kaye S. (2001), “Physical injecting sites among injecting drug users in Sydney, Australia”, Drug Alcohol Depend, 1, 62(1): 77-82.
  5. Winstock A.R., Nittis M., Whitton G., Lea T (2009), “Opioid dependent patients’ experiences of and attitudes towards having their injecting sites
  6. examined”, Int J Drug Policy, 20(1): 85-9.
  7. Fields J.M.,Piela N.E., Au A.K., Ku B.S. (2014), “Risk factors associated with difficult venous access in adult ED patients”, Am J Emerg Med, 32(10): 1179-82.
  8. Coffin P.O.,Coffin L.S., Murphy S., Jenkins L.M., Golden M.R. (2012), “Prevalence and characteristics of femoral injection among Seattle-area
  9. injection drug users”, J Urban Health, 89(2): 365-72.
  10. Presidenza del Consiglio dei Ministri, Dipartimento Politiche Antidroga (2011), Linee di indirizzo per lo screening e la diagnosi precoce delle principali patologie infettive correlate all’uso di sostanze stupefacenti nei Dipartimenti delle Dipendenze, Roma. Disponibile da: www.iss.it/binary/ccoa/cont/Linee_di_Indirizzo_screening.pdf [consultato il 09/10/2015].
  11. Saiani L., Brugnolli A. (2011), Trattato di cure infermieristiche, Idelson- Gnocchi, Napoli: 1059.
  12. Maliphant J., Scott J. (2005), “Use of the femoral vein (‘groin injecting’)
  13. by a sample of needle exchange clients in Bristol, UK”, Harm Reduct J, 15, 2(1): 6.
  14. Cavallo D., Re Luca G., Lusignani M. (2013), “Caratteristiche ed efficacia della relazione terapeutica tra infermiere e utente: una revisione della letteratura”, L’infermiere, 50:6: e99-e109.
  15. Nyström M. (2007), “A patient-oriented perspective in existential issues: a theoretical argument for applying Peplau’s interpersonal relation model in healthcare science and practice”, Scand J Caring Sci, 21(2): 282-8.
  16. Salmon A.M., Dwyer R., Jauncey M., van Beek I., Topp L., Maher L. (2009), “Injecting-related injury and disease among clients of a supervised injecting facility”, Drug Alcohol Depend, 101(1-2): 132-6.

Metrics

Metrics Loading ...